GlassScriptPhysician profile
Mecker G Moller
NPI 1962601492
$25,010.49
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2021: $247 · 2022: $395 · 2023: $333 · 2024: $11K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $2,270 · Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,084.47 |
| Travel and Lodging | $2,270.14 |
| Food and Beverage | $1,389.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $20,436.97 | 2024-2025 | Enseal, Harmonic, Echelon; Endopath |
| Medical Device Business Services, INC. | $2,395.44 | 2024-2025 | |
| Medtronic, INC. | $685.82 | 2023-2025 | Signia, Progrip, Ligasure |
| Hologic INC | $578.96 | 2021-2022 | |
| Covidien LP | $575.00 | 2019 | |
| Endomagnetics LTD | $150.53 | 2023 | Magseed, Magtrace |
| Endolumik, INC. | $75.00 | 2025 | Endolumik Gastric Calibration Tube |
| Sanara Medtech INC. | $63.03 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $49.74 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mecker Moller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.